| Phosphatidylserine is a global immunosuppressive signal in efferocytosis, infectious disease, and cancer RB Birge, S Boeltz, S Kumar, J Carlson, J Wanderley, D Calianese, ... Cell Death & Differentiation 23 (6), 962-978, 2016 | 692 | 2016 |
| Anti-CD19 CAR T cell therapy for refractory systemic lupus erythematosus A Mackensen, F Müller, D Mougiakakos, S Böltz, A Wilhelm, M Aigner, ... Nature medicine 28 (10), 2124-2132, 2022 | 622 | 2022 |
| To NET or not to NET: current opinions and state of the science regarding the formation of neutrophil extracellular traps S Boeltz, P Amini, HJ Anders, F Andrade, R Bilyy, S Chatfield, I Cichon, ... Cell Death & Differentiation 26 (3), 395-408, 2019 | 440 | 2019 |
| CD19-targeted CAR T cells in refractory systemic lupus erythematosus D Mougiakakos, G Krönke, S Völkl, S Kretschmann, M Aigner, ... New England Journal of Medicine 385 (6), 567-569, 2021 | 367 | 2021 |
| Neutrophil extracellular traps initiate gallstone formation LE Muñoz, S Boeltz, R Bilyy, C Schauer, A Mahajan, N Widulin, ... Immunity 51 (3), 443-450. e4, 2019 | 162 | 2019 |
| CD19-targeted CAR T cells in refractory antisynthetase syndrome F Müller, S Boeltz, J Knitza, M Aigner, S Völkl, S Kharboutli, H Reimann, ... The Lancet 401 (10379), 815-818, 2023 | 148 | 2023 |
| Treatment of a patient with severe systemic sclerosis (SSc) using CD19-targeted CAR T cells C Bergmann, F Müller, JHW Distler, AH Györfi, S Völkl, M Aigner, ... Annals of the rheumatic diseases 82 (8), 1117-1120, 2023 | 120 | 2023 |
| Working with “H2S”: facts and apparent artifacts R Wedmann, S Bertlein, I Macinkovic, S Böltz, JL Miljkovic, LE Muñoz, ... Nitric Oxide 41, 85-96, 2014 | 116 | 2014 |
| UBE2L3 polymorphism amplifies NF-κB activation and promotes plasma cell development, linking linear ubiquitination to multiple autoimmune diseases MJ Lewis, S Vyse, AM Shields, S Boeltz, PA Gordon, TD Spector, ... The American Journal of Human Genetics 96 (2), 221-234, 2015 | 108 | 2015 |
| Cleaved N-terminal histone tails distinguish between NADPH oxidase (NOX)-dependent and NOX-independent pathways of neutrophil extracellular trap formation E Pieterse, N Rother, C Yanginlar, J Gerretsen, S Boeltz, LE Munoz, ... Annals of the rheumatic diseases 77 (12), 1790-1798, 2018 | 107 | 2018 |
| Sweet but dangerous–the role of immunoglobulin G glycosylation in autoimmunity and inflammation MHC Biermann, G Griffante, MJ Podolska, S Boeltz, J Stürmer, LE Muñoz, ... Lupus 25 (8), 934-942, 2016 | 106 | 2016 |
| Reactive oxygen homeostasis–the balance for preventing autoimmunity D Kienhöfer, S Boeltz, MH Hoffmann Lupus 25 (8), 943-954, 2016 | 55 | 2016 |
| Rescue therapy of antisynthetase syndrome with CD19-targeted CAR-T cells after failure of several B-cell depleting antibodies J Taubmann, J Knitza, F Müller, S Völkl, M Aigner, A Kleyer, R Gary, ... Rheumatology 63 (1), e12-e14, 2024 | 49 | 2024 |
| Accuracy and tolerability of self-sampling of capillary blood for analysis of inflammation and autoantibodies in rheumatoid arthritis patients—results from a randomized … J Knitza, K Tascilar, N Vuillerme, E Eimer, P Matusewicz, G Corte, ... Arthritis research & therapy 24 (1), 125, 2022 | 46 | 2022 |
| Neutrophil extracellular traps open the Pandora’s box in severe malaria S Boeltz, LE Muñoz, TA Fuchs, M Herrmann Frontiers in Immunology 8, 874, 2017 | 37 | 2017 |
| Remote self-collection of capillary blood using upper arm devices for autoantibody analysis in patients with immune-mediated inflammatory rheumatic diseases J Zarbl, E Eimer, C Gigg, G Bendzuck, M Korinth, C Elling-Audersch, ... RMD open 8 (2), e002641, 2022 | 32 | 2022 |
| Patient's perception of digital symptom assessment technologies in rheumatology: results from a multicentre study J Knitza, F Muehlensiepen, Y Ignatyev, F Fuchs, J Mohn, D Simon, ... Frontiers in Public Health 10, 844669, 2022 | 32 | 2022 |
| Autoimmune, rheumatic, chronic inflammatory diseases: neutrophil extracellular traps on parade MJ Podolska, A Mahajan, J Knopf, J Hahn, S Boeltz, L Munoz, R Bilyy, ... Autoimmunity 51 (6), 281-287, 2018 | 27 | 2018 |
| Towards a pro-resolving concept in systemic lupus erythematosus S Boeltz, M Hagen, J Knopf, A Mahajan, M Schick, Y Zhao, C Erfurt-Berge, ... Seminars in immunopathology 41, 681-697, 2019 | 23 | 2019 |
| OP0141 long term safety and efficacy of CAR-T cell treatment in refractory systemic lupus erythematosus-data from the first seven patients J Taubmann, F Müller, S Boeltz, S Völkl, M Aigner, A Kleyer, ... Annals of the Rheumatic Diseases 82, 93-94, 2023 | 17 | 2023 |
PD Dr. Luis E. MunozFriedrich-Alexander Universität Erlangen-NürnbergVerifisert e-postadresse på uk-erlangen.de
